|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | |
| A61P 35/00 | |||
| A61P 13/06 | |||
| C12N 9/16 |
| (11) | Number of the document | 2768526 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12842640.0 |
| Date of filing the European patent application | 2012-10-18 | |
| (97) | Date of publication of the European application | 2014-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/060869 |
| Date | 2012-10-18 |
| (87) | Number | WO 2013/059491 |
| Date | 2013-04-25 |
| (30) | Number | Date | Country code |
| 201161549047 P | 2011-10-19 | US | |
| 201261649717 P | 2012-05-21 | US |
| (72) |
CRINE, Philippe, CA
ELEFTERIOU, Florent, CA
|
| (73) |
Vanderbilt University,
305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240,
US
Alexion Pharmaceuticals, Inc., 100 College Street, New Haven, CT 06510, US |
| (54) | COMPOSITIONS COMPRISING ALKALINE PHOSPHATASE AND/OR NATRIURETIC PEPTIDE AND METHODS OF USE THEREOF |
| COMPOSITIONS COMPRISING ALKALINE PHOSPHATASE AND/OR NATRIURETIC PEPTIDE AND METHODS OF USE THEREOF |